Bright Minds Biosciences Inc (DRUG.CX)
49.40
+4.22
(+9.34%)
CAD |
CNSX |
Nov 22, 16:00
Bright Minds Biosciences Total Assets (Quarterly): 6.278M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 6.278M |
March 31, 2024 | 6.531M |
December 31, 2023 | 6.887M |
September 30, 2023 | 6.879M |
June 30, 2023 | 8.460M |
March 31, 2023 | 9.987M |
December 31, 2022 | 11.55M |
September 30, 2022 | 12.09M |
Date | Value |
---|---|
June 30, 2022 | 8.820M |
March 31, 2022 | 11.76M |
December 31, 2021 | 15.41M |
September 30, 2021 | 20.04M |
June 30, 2021 | 22.22M |
March 31, 2021 | 25.74M |
December 31, 2020 | 2.184M |
September 30, 2020 | 0.8802M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.8802M
Minimum
Sep 2020
25.74M
Maximum
Mar 2021
10.98M
Average
9.403M
Median
Total Assets (Quarterly) Benchmarks
4Front Ventures Corp | 375.66M |
Green Thumb Industries Inc | 3.397B |
Lowell Farms Inc | 38.42M |
StateHouse Holdings Inc | 166.32M |
Vireo Growth Inc | 261.89M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 0.1786M |
Shareholders Equity (Quarterly) | 6.099M |